Stacey Nicole Schaeffer Orlov, an officer of Insmed Inc, filed a Form 144 notice of proposed sale on November 19, 2026, covering 101,100 shares of Insmed common stock with an aggregate market value of $14,684,816.
Key Highlights
- Selling officer: Stacey Nicole Schaeffer Orlov, identified as an officer of Insmed Inc.
- Shares proposed for sale: 101,100 shares of Insmed common stock.
- Aggregate market value: $14,684,816, according to the filing.
- Shares outstanding: 219,380,309 shares of common stock outstanding at the time of filing.
- Nature of acquisition: Securities were acquired through stock plan activity from the issuer on November 19, 2026.
- Rule 10b5-1 plan: The filing indicates a plan adoption date of May 11, 2026.
- No prior sales: The filing reports nothing to disclose for securities sold during the past three months.
Insmed Officer Proposes Sale Under Rule 144 with 10b5-1 Plan Dated May 2026
According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission on November 19, 2026, Stacey Nicole Schaeffer Orlov, an officer of Insmed Inc (NASDAQ:INSM), provided notice of a proposed sale of 101,100 shares of the company's common stock. The filing lists the broker facilitating the transaction as Merrill Lynch, located at 1800 K St NW, Suite 800, Washington, DC 20006, with an approximate sale date of November 19, 2026.
The filing states that the securities to be sold were acquired on November 19, 2026, through stock plan activity from the issuer. The aggregate market value of the proposed sale is listed as $14,684,816. At the time of the filing, Insmed's total shares of common stock outstanding were reported as 219,380,309. The filing notes no securities were sold by the reporting person during the past three months.
The filing further discloses that the sale is being made in reliance on a Rule 10b5-1 written trading plan, with the date of plan adoption listed as May 11, 2026. By signing the notice, the filing states that the person for whose account the securities are to be sold represents that she "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed," as of the plan adoption date. Insmed Inc is headquartered at 700 US Highway 202/206, Bridgewater, New Jersey 08807.
What Was Disclosed
Insmed officer Stacey Nicole Schaeffer Orlov filed a Form 144 notice on November 19, 2026, proposing to sell 101,100 shares of Insmed common stock valued at $14,684,816 in aggregate, acquired through stock plan activity, under a Rule 10b5-1 plan adopted May 11, 2026.




Please wait processing your request...